Skip to Content

RDY 226 (Lamotrigine (chewable, dispersible) 25 mg)

Pill imprint RDY 226 has been identified as Lamotrigine (chewable, dispersible) 25 mg.

Lamotrigine is used in the treatment of bipolar disorder; anxiety; schizoaffective disorder; borderline personality disorder; seizure prevention (and more), and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 25 mg is not a controlled substance under the Controlled Substance Act (CSA).

Lamotrigine (chewable, dispersible) 25 mg RDY 226
Lamotrigine (chewable, dispersible) 25 mg RDY 226
Discount Card Promo
Lamotrigine (chewable, dispersible)
Imprint:
RDY 226
Strength:
25 mg
Color:
White
Size:
13.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Triazine anticonvulsants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Dr. Reddy’s Laboratories Inc.
National Drug Code (NDC):
55111-0226
Inactive Ingredients:
silicon dioxide
crospovidone
magnesium stearate
mannitol
microcrystalline cellulose
corn starch
magnesium silicate
black currant

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide